The next generation
As large cap pharma continues to search for new first in class products it is the biotechnology sector that may provide the answers.
Having matured from its startup origins the biotechnology industry has been characterized by big wins, big failures and an ever changing technical and commercial relationship with its big pharma peers. Success in the biotechnology business demands deep sector insight, class leading business skills and sharp financial acumen. Deloittes global life science practice has the sector specialists, financial and operational experience to help you succeed.
Deloitte has extensive relationships with pharmaceutical companies across the whole spectrum of size and geography.